Exhibit 99.1
Albemarle Corporation and Subsidiaries
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands, Except Per Share Amounts; Unaudited)
| | | | | | | | | | | | |
Nine Months Ended September 30, 2012 | | As Previously Reported | | | Effect of Accounting Change | | | As Adjusted | |
| | | |
Net sales | | $ | 2,057,824 | | | $ | — | | | $ | 2,057,824 | |
Cost of goods sold | | | 1,352,495 | | | | (12,689 | ) | | | 1,339,806 | |
| | | | | | | | | | | | |
Gross profit | | | 705,329 | | | | 12,689 | | | | 718,018 | |
Selling, general and administrative expenses | | | 215,298 | | | | (26,155 | ) | | | 189,143 | |
Research and development expenses | | | 59,791 | | | | — | | | | 59,791 | |
Restructuring and other charges | | | 101,211 | | | | (6,508 | ) | | | 94,703 | |
| | | | | | | | | | | | |
Operating profit | | | 329,029 | | | | 45,352 | | | | 374,381 | |
Interest and financing expenses | | | (25,134 | ) | | | — | | | | (25,134 | ) |
Other income, net | | | 1,564 | | | | — | | | | 1,564 | |
| | | | | | | | | | | | |
Income before income taxes and equity in net income of unconsolidated investments | | | 305,459 | | | | 45,352 | | | | 350,811 | |
Income tax expense | | | 76,804 | | | | 16,578 | | | | 93,382 | |
| | | | | | | | | | | | |
Income before equity in net income of unconsolidated investments | | | 228,655 | | | | 28,774 | | | | 257,429 | |
Equity in net income of unconsolidated investments (net of tax) | | | 29,233 | | | | — | | | | 29,233 | |
| | | | | | | | | | | | |
Net income | | $ | 257,888 | | | $ | 28,774 | | | $ | 286,662 | |
Net income attributable to noncontrolling interests | | | (12,852 | ) | | | — | | | | (12,852 | ) |
| | | | | | | | | | | | |
Net income attributable to Albemarle Corporation | | $ | 245,036 | | | $ | 28,774 | | | $ | 273,810 | |
| | | | | | | | | | | | |
Basic earnings per share | | $ | 2.75 | | | $ | 0.32 | | | $ | 3.07 | |
| | | | | | | | | | | | |
Diluted earnings per share | | $ | 2.72 | | | $ | 0.32 | | | $ | 3.04 | |
| | | | | | | | | | | | |
Weighted-average common shares outstanding – basic | | | 89,246 | | | | — | | | | 89,246 | |
| | | | | | | | | | | | |
Weighted-average common shares outstanding – diluted | | | 89,959 | | | | — | | | | 89,959 | |
| | | | | | | | | | | | |
Cash dividends declared per share of common stock | | $ | 0.60 | | | $ | — | | | $ | 0.60 | |
| | | | | | | | | | | | |
| | |
| | Exhibit 99.1 |
Albemarle Corporation and Subsidiaries | | |
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands, Except Per Share Amounts; Unaudited)
| | | | | | | | | | | | |
Year Ended December 31, 2011 | | As Previously Reported | | | Effect of Accounting Change | | | As Adjusted | |
| | | |
Net sales | | $ | 2,869,005 | | | $ | — | | | $ | 2,869,005 | |
Cost of goods sold | | | 1,891,946 | | | | 22,112 | | | | 1,914,058 | |
| | | | | | | | | | | | |
Gross profit | | | 977,059 | | | | (22,112 | ) | | | 954,947 | |
Selling, general and administrative expenses | | | 312,136 | | | | 47,934 | | | | 360,070 | |
Research and development expenses | | | 77,083 | | | | — | | | | 77,083 | |
| | | | | | | | | | | | |
Operating profit | | | 587,840 | | | | (70,046 | ) | | | 517,794 | |
Interest and financing expenses | | | (37,574 | ) | | | — | | | | (37,574 | ) |
Other income, net | | | 357 | | | | — | | | | 357 | |
| | | | | | | | | | | | |
Income before income taxes and equity in net income of unconsolidated investments | | | 550,623 | | | | (70,046 | ) | | | 480,577 | |
Income tax expense | | | 130,014 | | | | (25,880 | ) | | | 104,134 | |
| | | | | | | | | | | | |
Income before equity in net income of unconsolidated investments | | | 420,609 | | | | (44,166 | ) | | | 376,443 | |
Equity in net income of unconsolidated investments (net of tax) | | | 43,754 | | | | — | | | | 43,754 | |
| | | | | | | | | | | | |
Net income | | $ | 464,363 | | | $ | (44,166 | ) | | $ | 420,197 | |
Net income attributable to noncontrolling interests | | | (28,083 | ) | | | — | | | | (28,083 | ) |
| | | | | | | | | | | | |
Net income attributable to Albemarle Corporation | | $ | 436,280 | | | $ | (44,166 | ) | | $ | 392,114 | |
| | | | | | | | | | | | |
Basic earnings per share | | $ | 4.82 | | | $ | (0.49 | ) | | $ | 4.33 | |
| | | | | | | | | | | | |
Diluted earnings per share | | $ | 4.77 | | | $ | (0.49 | ) | | $ | 4.28 | |
| | | | | | | | | | | | |
Weighted-average common shares outstanding – basic | | | 90,522 | | | | — | | | | 90,522 | |
| | | | | | | | | | | | |
Weighted-average common shares outstanding – diluted | | | 91,522 | | | | — | | | | 91,522 | |
| | | | | | | | | | | | |
Cash dividends declared per share of common stock | | $ | 0.67 | | | $ | — | | | $ | 0.67 | |
| | | | | | | | | | | | |
| | |
| | Exhibit 99.1 |
Albemarle Corporation and Subsidiaries | | |
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands, Except Per Share Amounts; Unaudited)
| | | | | | | | | | | | |
Year Ended December 31, 2010 | | As Previously Reported | | | Effect of Accounting Change | | | As Adjusted | |
| | | |
Net sales | | $ | 2,362,764 | | | $ | — | | | $ | 2,362,764 | |
Cost of goods sold | | | 1,616,842 | | | | 4,012 | | | | 1,620,854 | |
| | | | | | | | | | | | |
Gross profit | | | 745,922 | | | | (4,012 | ) | | | 741,910 | |
Selling, general and administrative expenses | | | 265,722 | | | | 8,893 | | | | 274,615 | |
Research and development expenses | | | 58,394 | | | | — | | | | 58,394 | |
Restructuring and other charges | | | 6,958 | | | | — | | | | 6,958 | |
| | | | | | | | | | | | |
Operating profit | | | 414,848 | | | | (12,905 | ) | | | 401,943 | |
Interest and financing expenses | | | (25,533 | ) | | | — | | | | (25,533 | ) |
Other income, net | | | 2,788 | | | | — | | | | 2,788 | |
| | | | | | | | | | | | |
Income before income taxes and equity in net income of unconsolidated investments | | | 392,103 | | | | (12,905 | ) | | | 379,198 | |
Income tax expense | | | 92,719 | | | | (4,963 | ) | | | 87,756 | |
| | | | | | | | | | | | |
Income before equity in net income of unconsolidated investments | | | 299,384 | | | | (7,942 | ) | | | 291,442 | |
Equity in net income of unconsolidated investments (net of tax) | | | 37,975 | | | | — | | | | 37,975 | |
| | | | | | | | | | | | |
Net income | | $ | 337,359 | | | $ | (7,942 | ) | | $ | 329,417 | |
Net income attributable to noncontrolling interests | | | (13,639 | ) | | | — | | | | (13,639 | ) |
| | | | | | | | | | | | |
Net income attributable to Albemarle Corporation | | $ | 323,720 | | | $ | (7,942 | ) | | $ | 315,778 | |
| | | | | | | | | | | | |
Basic earnings per share | | $ | 3.54 | | | $ | (0.08 | ) | | $ | 3.46 | |
| | | | | | | | | | | | |
Diluted earnings per share | | $ | 3.51 | | | $ | (0.08 | ) | | $ | 3.43 | |
| | | | | | | | | | | | |
Weighted-average common shares outstanding – basic | | | 91,393 | | | | — | | | | 91,393 | |
| | | | | | | | | | | | |
Weighted-average common shares outstanding – diluted | | | 92,184 | | | | — | | | | 92,184 | |
| | | | | | | | | | | | |
Cash dividends declared per share of common stock | | $ | 0.56 | | | $ | — | | | $ | 0.56 | |
| | | | | | | | | | | | |